- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/50 - Microcapsules
Patent holdings for IPC class A61K 9/50
Total number of patents in this class: 6230
10-year publication summary
|
465
|
587
|
550
|
557
|
626
|
531
|
566
|
513
|
423
|
136
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
75 |
| DSM IP Assets B.V. | 5856 |
48 |
| Evonik Operations GmbH | 3879 |
46 |
| The Johns Hopkins University | 5377 |
44 |
| Sol-gel Technologies Ltd. | 170 |
44 |
| BASF SE | 19740 |
40 |
| Tris Pharma, Inc. | 91 |
40 |
| Massachusetts Institute of Technology | 9795 |
36 |
| Société des Produits Nestlé S.A. | 9672 |
30 |
| Sun Pharmaceutical Industries Limited | 706 |
30 |
| Johnson & Johnson Consumer Inc. | 1277 |
30 |
| Board of Regents, The University of Texas System | 5370 |
28 |
| Children's Medical Center Corporation | 1780 |
28 |
| The Procter & Gamble Company | 22178 |
27 |
| President and Fellows of Harvard College | 5792 |
27 |
| Novartis AG | 11238 |
26 |
| Takeda Pharmaceutical Company Limited | 2961 |
26 |
| Nanexa AB | 39 |
26 |
| Sublimity Therapeutics Limited | 39 |
26 |
| Evonik Röhm GmbH | 452 |
25 |
| Other owners | 5528 |